News

Beijing Biocytogen Company Name Change Annuncement

Effective December 29th, 2020, our parent company name has officially changed from Beijing Biocytogen Co., Ltd. to Biocytogen Pharmaceuticals (Beijing) Co., Ltd. There is no…

Read more
Biocytogen Enters into RenMab™/RenLite™ Licensing Agreement with Xencor

Xencor to use RenLite™ Fully Human Antibody Mouse Platform to discover novel antibody drugs WAKEFIELD, Mass. and BEIJING, Dec. 7, 2020 /PRNewswire/--Beijing Biocytogen Co., Ltd. , Biocytogen Boston…

Read more
Biocytogen Teams With Ina Research To Boost Presence In Japan

Beijing, China and Nagano, Japan; November 30, 2020-Beijing Biocytogen Co., Ltd. (hereinafter “Biocytogen”) announced today that it has entered into a commercial agency agreement with…

Read more
Festival of Biologics Basel 2020

Therapeutic Antibody Hit Generation Using Fully Human Antibody Transgenic Mice RenMab™ and RenLite™ Speaker: Qingcong Lin, CEO of Biocytogen Boston Corp Time: 1:30pm GMT/8:30am ET,…

Read more
Immuno-Oncology Summit Virtual Summit 2020

About the Immuno-Oncology Summit Over the past 8 years, CHI's Immuno-Oncology Summit has become the leading annual meeting focusing on the latest applied research, providing…

Read more
Emerging biotechnology company Biocytogen raised 142 million dollars (USD) in support of Project Integrum

BEIJING and BOSTON, Sept. 24, 2020 /PRNewswire/ -- In August, Beijing Biocytogen Biotechnology Co., Ltd. ("Biocytogen") announced acquisition of Eucure Biopharma, which established Biocytogen as a clinical stage…

Read more
Strategic collaboration agreement reached between Biocytogen and Berkeley Lights for second Beacon Optofluidic system

September 14, 2020, Beijing | Beijing Biocytogen Co., Ltd. ("Biocytogen") reached a collaboration with Berkeley Lights Inc. ("Berkeley Lights") on the introduction of the second…

Read more
PEGS Boston Virtual Summit

Presentation Title: Accelerating Therapeutic Antibody Discovery with Three Distinct Humanized Mouse Models Time: 9:45 AM - 10:10 AM EDT on Monday, August 31 Programs: Antibody…

Read more
RenMab™ and RenLite™ Models Featured in GEN Magazine

In the August issue of Genetic Engineering & Biotechnology News, Biocytogen's RenMab (fully human antibody mouse) and RenLite (common light chain) models are introduced in the…

Read more
RenMab™ Mouse Platform Drives SARS CoV-2 Neutralizing Antibody Cocktail Therapy Towards Clinical Trials in Biocytogen and Eucure Biopharma Partnership

[MA, USA and Beijing, China - August]  The COVID-19 pandemic has been an inescapable, lethal, and overwhelming aspect of daily human life, threatening health and…

Read more
Back to top